← All organizations
Highest phase reached
Phase 4
First clinical trial
Jun 1, 2012Last known activity
Feb 5, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (9 distinct, 6 trials)
Phase 4 (4 own, 0 via acquisition)
Other trials (3 own, 0 via acquisition)
Indications
Recent trials (13)
- NCT06230900CollaboratorN/AFeb 5, 2024
- NCT05407194Lead sponsorN/ASep 30, 2022
- NCT05407194Reponsible party - principal investigatorN/ASep 30, 2022
- NCT05405764Sponsor investigatorN/AApr 19, 2022
- NCT05405764CollaboratorN/AApr 19, 2022
- NCT05405764OfficialN/AApr 19, 2022
- NCT05405764Lead sponsorN/AApr 19, 2022
- NCT05405764Overall official - principal investigatorN/AApr 19, 2022
- NCT03509662CollaboratorPhase 2Oct 1, 2018
- NCT02317198CollaboratorPhase 4Jun 1, 2013
- NCT01362959Overall official - principal investigatorPhase 4Jun 1, 2012
- NCT01362959Lead sponsorPhase 4Jun 1, 2012
- NCT01362959Reponsible party - principal investigatorPhase 4Jun 1, 2012
Details
- Founded
- Ede, NL
- Last known activity
- Feb 5, 2024